Cafepharma Today

January 23 2024 - AbbVie pulls off a hat trick with 3rd straight year as top TV drug ad spender
AbbVie pulls off a hat trick with 3rd straight year as top TV drug ad spender
FDA tacks boxed warning on Teva’s Copaxone, other MS drugs
RFK Jr. plans to keep a financial stake in lawsuits against the drugmaker Merck
Biogen research team hit by layoffs as company shifts resources to external opportunities
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Even Pfizer Has Fallen Upon Some Hard Times
The Day, CT
Sunday, January 18, 2009 - 12:10pm
tags:
Pfizer
China Biopharma Continues to Expand Offerings
Seeking Alpha
Sunday, January 18, 2009 - 12:05pm
tags:
China, biotech
Lundbeck may have revived its interest in Elan
Irish Independent, Ireland
Sunday, January 18, 2009 - 12:04pm
tags:
Elan, Lundbeck
WuXi Gains From Pfizer's Loss
Seeking Alpha
Sunday, January 18, 2009 - 11:15am
tags:
WuXi PharmaTech, Pfizer
Perspective on Pfizer Layoffs
Seeking Alpha
Sunday, January 18, 2009 - 11:14am
tags:
Pfizer
'Pharma industry (in India) not impacted by global slowdown'
The Hindu, India
Saturday, January 17, 2009 - 9:18am
tags:
India
Warner Chilcott files suit to protect Doryx patent
MSNBC
Saturday, January 17, 2009 - 9:16am
tags:
Warner Chilcott, DORYX
Cornerstone Biopharma steps into ring with Merck, AstraZeneca
Triangle Business Journal, NC
Saturday, January 17, 2009 - 9:14am
tags:
Cornerstone Therapeutics, Merck, AstraZeneca, asthma
New drug for treatment of acne
MSNBC
Saturday, January 17, 2009 - 9:13am
tags:
acne
Peptimmune, Novartis Sign $500M Deal for MS Drug
Bioworld
Saturday, January 17, 2009 - 9:12am
tags:
PeptImmune, Novartis, MS, multiple sclerosis
Indevus Pharmaceuticals (NASDAQ: IDEV) Investors: Shareholder Lawsuit On In Effort to Stop Sale IDEV With An ‘Unfair Price' Under Given Conditions Filed
PR-Inside
Saturday, January 17, 2009 - 9:09am
tags:
Indevus
What’s Not Up With Off-Label Use Economic Loss Claims
Drug and Device Law
Saturday, January 17, 2009 - 9:06am
tags:
off label
Aurobindo Pharma gets final approval for Levetiracetam Tablets
Stock Watch, India
Saturday, January 17, 2009 - 9:02am
tags:
Levetiracetam, Aurobindo
Multiple Myeloma Research Consortium (MMRC) and Merck Initiate Phase II Trial of Zolinza with Velcade in Relapsed and Refractory Multiple Myeloma Patients
Earth Times
Saturday, January 17, 2009 - 9:01am
tags:
Merck, Zolinza, Velcade, Multiple Myeloma
The Incredible Shrinking Pfizer?
Forbes
Saturday, January 17, 2009 - 8:59am
tags:
Pfizer
Orchid Chem up nearly 4% on new drug nod (Levetiracetam)
Business Standard, India
Saturday, January 17, 2009 - 8:57am
tags:
Levetiracetam
Roche Reportedly to cut 780 Positions Over Next 2-3 Years - Quick Facts
RTT News
Saturday, January 17, 2009 - 8:54am
tags:
Roche
Cypress Pharmaceutical, Inc. Receives FDA Approval of Levetiracetam Oral Solution
Earth Times
Saturday, January 17, 2009 - 8:53am
tags:
Cypress Bioscience, Levetiracetam
Highlights From the J.P. Morgan Health Confab
The Street
Saturday, January 17, 2009 - 8:50am
tags:
Gilead Sciences to Release Fourth Quarter and Year End 2008 Financial Results on Tuesday, January 27, 2009
Yahoo
Saturday, January 17, 2009 - 8:48am
tags:
Gilead Sciences

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline
The Current Environment
In the Pipeline
Informa Connect's Patient Assistance & Access Programs (PAP)
Drug Channels
2025 Brand Drug Challenges: A GoodRx Perspective
Drug Channels
Snake Antivenoms, Computed
In the Pipeline
Versatile Chaperones
In the Pipeline
Dealing With Being a Tumor Cell
In the Pipeline
Why 340B Reform Could Happen in 2025 (video)
Drug Channels

Latest Jobs

Onsite Endoscopic Specialist - Operating Room Support
Santa Monica, California
KARL STORZ Endoscopy - America
Area Manager, Immunology Rochester, NY Territory
Fields, Oregon, 97710
CSL Behring
Psychiatry Account Manager - Tarrytown, NY
Tarrytown, New York
Lundbeck
Area Manager Specialty, West- Central
Fields, Oregon, 97710
CSL Behring
Area Sale Manager, Immunology Tampa North
Fields, Oregon, 97710
CSL Behring
Sales Representative
Boise, Idaho, 83708
Bartlett Roofing
Capital Project Manager
Carteret, New Jersey, United States
The Spear Group
Area Manager Specialty, West
Fields, Oregon, 97710
CSL Behring
Psychiatry Account Manager - Midland, TX
Midland, Texas, 79701
Lundbeck
Home Health and Medical Sales
The Woodlands, Texas, 77381
Comfort Keepers of Dallas TX
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information